Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Larry Maxwell

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
NPJ Precision Oncology|November 4, 2023
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapySara Corvigno, Sunil Badal, Meredith L Spradlin, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
Journal of Women'S Health (2002)|January 13, 2023
A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF RegistryRaymond M Anchan, Daniel Wojdyla, Pietro Bortoletto, et al.
Iscience|July 19, 2021
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimensAllison L Hunt, Nicholas W Bateman, Waleed Barakat, et al.
Gynecologic Oncology|February 10, 2024
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factorsCalen W Kucera, Nicole P Chappell, Chunqiao Tian, et al.
American Journal of Obstetrics and Gynecology|May 27, 2023
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroidsRaymond M Anchan, James B Spies, Shuaiqi Zhang, et al.
Gynecologic Oncology|January 26, 2024
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypesStuart S Winkler, Chunqiao Tian, Yovanni Casablanca, et al.
Iscience|January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestryNicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
NPJ Precision Oncology|November 4, 2023
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapySara Corvigno, Sunil Badal, Meredith L Spradlin, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
European Radiology Experimental|December 6, 2023
Deep learning-based segmentation of multisite disease in ovarian cancerThomas Buddenkotte, Leonardo Rundo, Ramona Woitek, et al.
Journal of Women'S Health (2002)|January 13, 2023
A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF RegistryRaymond M Anchan, Daniel Wojdyla, Pietro Bortoletto, et al.
Iscience|July 19, 2021
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimensAllison L Hunt, Nicholas W Bateman, Waleed Barakat, et al.
Gynecologic Oncology|February 10, 2024
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factorsCalen W Kucera, Nicole P Chappell, Chunqiao Tian, et al.
American Journal of Obstetrics and Gynecology|May 27, 2023
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroidsRaymond M Anchan, James B Spies, Shuaiqi Zhang, et al.
Gynecologic Oncology|January 26, 2024
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypesStuart S Winkler, Chunqiao Tian, Yovanni Casablanca, et al.
Iscience|January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestryNicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
Pageof 16